Cervical Adenocarcinoma, a Novel Combination Chemotherapy with Mitomycin C, Etoposide, and Cisplatin for Advanced or Recurrent Disease

By Umesaki N.   Izumi R.   Fushiki H.   Hasegawa K.   Kono I.   Nishida M.   Noguchi H.   Okuda H.   Sugimori H.   Takizawa K.   Udagawa Y.   Yamamoto K.   Tanaka T.   Noda K.  

Gynecologic Oncology, Vol. 75, Iss. 1, 1999-10 ,pp. : 142-144

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Doxorubicin, 5-Fluorouracil, Etoposide, and Cisplatin in Advanced or Recurrent Endometrial Carcinoma

By Pierga J.-Y.   Dieras V.   Beuzeboc P.   Dorval T.   Palangie T.   Jouve M.   Scholl S.M.   Garcia-Giralt E.   Pouillart P.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 246-249

Elsevier

Access to resources Recommend Favorite

Treatment of Advanced or Recurrent Endometrial Carcinoma with Combination of Etoposide, Cisplatin, and 5-Fluorouracil: A Phase II Study

By Pierga J.Y.   Dieras V.   Paraiso D.   Dorval T.   Palangie T.   Beuzeboc P.   Jouve M.   Scholl S.M.   Garcia-Giralt E.   Pouillart P.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 59-63

Academic Press

Access to resources Recommend Favorite

Chemotherapy for advanced and recurrent cervical carcinoma in the new era of upfront chemotherapy and radiation: Have we arrived?

By Monk Bradley  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 77-80

Informa Healthcare

Access to resources Recommend Favorite

Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: The SAKK experience

By Roth A.D.   Herrmann R.   Morant R.   Borner M.M.   Honegger H.P.   Obrist R.   Bacchi M.   Lange J.   Alberto P.   Castiglione M.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2126-2128

Elsevier

Access to resources Recommend Favorite